SCHEMBL7470623

SCHEMBL7470623

CCC(=O)c1c(CC)n(Cc2ccccc2Cl)c2cc(C(=O)O)ccc12

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 4/20 0.45
ALOX5AP P20292 1/20 0.44
MAPK8 P45983 1/20 0.43
TP53 P04637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
FABP4 P15090 1/20 0.43
PTPN11 Q06124 1/20 0.42
CCR2 P41597 1/20 0.42
KDM4E B2RXH2 1/20 0.41
TNF P01375 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
DPP4 P27487 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418877 0.92 SLC22A12 (0.43) SLC22A12ALOX5APMAPK8TP53RXFP1
SCHEMBL7420966 0.91 ALOX5AP (0.44) ALOX5APTP53RXFP1KDM4ETNF
SCHEMBL7467256 0.90 L3MBTL1 (0.49) SLC22A12ALOX5APTP53RXFP1FABP4
SCHEMBL7474701 0.89 MAPT (0.45) TP53KDM4ETNFNOD2NOD1
SCHEMBL7428819 0.88 ALOX5AP (0.47) SLC22A12ALOX5APTP53RXFP1FABP4
SCHEMBL7419060 0.88 L3MBTL1 (0.52) SLC22A12ALOX5APTP53RXFP1PTPN11
SCHEMBL7418329 0.86 SLC22A12 (0.50) SLC22A12ALOX5APTP53RXFP1FABP4
SCHEMBL7419326 0.84 SLC22A12 (0.45) SLC22A12ALOX5APTP53RXFP1FABP4
SCHEMBL7423106 0.83 ALOX5AP (0.42) ALOX5APTP53RXFP1KDM4ETNF
SCHEMBL7419529 0.83 TP53 (0.49) SLC22A12ALOX5APMAPK8TP53RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed